Teva Pharmaceutical Value Stock - Dividend - Research Selection
Teva Pharmaceutical
ISIN: US8816242098, WKN: 883035
Market price: 10,38 USD
Teva Pharmaceutical Fundamental data and company key figures of the share
| Annual reports in USD | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key figures | 25-02-2021 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Cash flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net operating cash flow | 1.216.000.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Expenditures | -578.000.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Free cash flow | 638.000.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance sheet | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total Equity | 10.026.000.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Liabilities & Shareholders equity | 50.640.000.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Income statement | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | -3.990.000.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Eps (diluted) | -0,916 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted shares outstanding | 1.095.000.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales/revenue | 16.659.000.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
| Description | Data |
|---|---|
| Symbol | TEVA |
| Market Capitalization | 11.628.900.352,00 USD |
| Country | |
| Indices | NO INDEX |
| Sectors | |
| Raw Data Source | US GAAP in Millionen USD |
| Stock Split | 2004-07-02,2.0000/1.0000; 2004-07-01,2.0000/1.0000; 2002-12-07,2.0000/1.0000; 2002-12-06,2.0000/1.0000; 2000-02-24,2.0000/1.0000; 2000-02-23,2.0000/1.0000; 2000-02-22,1.0000/1.0000; 1993-04-15,2.0000/1.0000; 1993-04-14,2.0000/1.0000; 1982-08-16,1.000000/1.000000 |
| Internet | www.tevapharm.com |
Description of the company
Teva Pharmaceutical Industries Ltd (Teva) is an Israel-based pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. Teva´s active pharmaceutical ingredient (API) business provides vertical integration to Teva´s own pharmaceutical production. The Company´s global operations are conducted from North and Latin America to Europe and Asia. Teva operates a number of subsidiaries in such countries as Canada, Croatia, the Czech Republic, France, Germany, Hungary, Ireland, Israel, Japan, Poland, the Russian Federation, Spain, the Netherlands, the United Kingdom and the United States.